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Objectives. This study compares the results of antimyosin scintig-
raphy in patients with clinically suspected myocarditis with histo-
logic and immunohistologic findings in the endomyocardial biopsy.
Background. In patients with clinically suspected myocarditis,
antimyosin scintigraphy often demonstrates myocardial cell dam-
age but histologic evaluation of the endomyocardial biopsy often
fails to show evidence of myocarditis. Recently developed immu-
nohistologic techniques appear to be more sensitive for the
detection of myocardial inflammation than histologic analysis
alone. Studies comparing antimyosin scintigraphy and immuno-
histologic analysis of the endomyocardial biopsy in patients with
clinically suspected myocarditis are not yet available.
Methods. Sixty-five patients with clinically suspected myocar-
ditis underwent antimyosin scintigraphy. Antimyosin antibody
uptake was correlated with histologic and immunohistologic find-
ings in the endomyocardial biopsy.
Results. Antimyosin scintigraphy showed evidence of myocar-
dial cell damage in 36 (55%) of the 65 patients and was negative
in 29 (45%) patients. Histologic analysis of the endomyocardial
biopsy revealed myocarditis in nine patients: six had a positive
and three had a negative antimyosin scan, respectively. Thirty
(83%) of 36 patients with evidence of myocardial cell damage on
antimyosin scintigraphy were histologically negative for myocar-
ditis. Immunohistologic analysis showed evidence of myocarditis
in 31 (86%) of 36 patients with a positive antimyosin scan and also
in 17 (59%) of 29 patients with a normal scan (p < 0.047).
Conclusions. Antimyosin scintigraphy often shows myocyte
injury in patients with clinically suspected myocarditis. Histologic
analysis of the endomyocardial biopsy alone is often negative, but
additional immunohistologic analysis of the endomyocardial bi-
opsy frequently provides evidence of myocardial inflammation in
these patients. With immunohistologic analysis as the reference
method, antimyosin scintigraphy has a high specificity but a lower
sensitivity for the detection of myocarditis.
(J Am Coll Cardiol 1998;32:1371–6)
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In patients with clinically suspected myocarditis, the diagnosis
is established by endomyocardial biopsy. Using histologic
criteria alone, the diagnostic value of the endomyocardial
biopsy has been questioned because of a low yield of diagnostic
biopsies in patients with recent onset heart failure of unknown
origin (1–3), probably due to sampling error (4,5). Addition-
ally, even when using uniform criteria (6), the histologic
analysis of the endomyocardial biopsy is associated with a high
interobserver variability (7). Recently, additional immunohis-
tologic methods have been developed using monoclonal anti-
bodies to detect and quantify lymphocytic infiltrates in the
myocardium and to analyze the expression of human lympho-
cyte antigen I and II antigens in the heart (8–12). Using these
techniques, the presence of a chronic inflammatory process has
been demonstrated in patients with dilated cardiomyopathy
(13). Unfortunately, immunohistology is unable to detect
myocyte damage, which is an obligatory component of myo-
carditis (6). Myocyte injury can be studied noninvasively by
determining myocardial uptake of indium-111–labeled mono-
clonal antimyosin antibodies. This method has been success-
fully used to detect very sensitive areas of myocardial infarc-
tion (14) and myocyte injury in cardiac transplant rejection and
anthracycline therapy (15–17).
In patients with clinically suspected myocarditis or dilated
cardiomyopathy, discrepancies between a high prevalence of
positive antimyosin scans and often negative histologic findings
in the endomyocardial biopsy have been reported (18–20),
indicating a high sensitivity but a low specificity of the anti-
myosin scintigraphy for the detection of myocarditis. No
studies are available comparing results of antimyosin scintig-
raphy with immunohistologic findings in endomyocardial bi-
opsy specimen.
The present study was performed to analyze the diagnostic
value of antimyosin scintigraphy in patients with clinically
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suspected myocarditis by comparing the results of antimyosin
scintigraphy with immunohistologic and histologic findings in
endomyocardial biopsy specimen.
Methods
Patient selection. Sixty-five patients (42 men, 23 women,
mean age 48.5 6 12.5 years, range 21 to 70) were studied who
presented with histories and clinical findings suggestive of
myocarditis. All patients underwent right and left heart cath-
eterization, left ventriculography, right ventricular endomyo-
cardial biopsy and antimyosin scintigraphy with monoclonal
antimyosin Fab labeled with indium-111. Coronary artery
disease was excluded by coronary angiography in all patients.
Forty-six patients presented with left ventricular dysfunc-
tion (left ventricular ejection fraction ,55%) demonstrated by
left ventriculography. Eleven patients presented with new
onset of anginal symptoms accompanied by electrocardio-
graphic changes (ST-segment depression or negative T waves)
that could be interpreted as myocardial ischemia. However,
other causes, like pericardial disease or myocardial hypertro-
phy, could not be excluded solely from the electrocardiogram.
Normal coronary arteries and no evidence of coronary spasm
were demonstrated by coronary angiography in all of these
patients. A small pericardial effusion was present in 3 patients,
and elevated creatine kinase levels were found in 4 of the 11
patients with anginal pain. New rhythm disturbances were the
presenting symptom in six patients (five with atrial fibrillation,
one with ventricular tachycardia). Two patients presented with
symptoms of heart failure and normal left ventricular systolic
function but hemodynamic changes suggesting left ventricular
diastolic dysfunction. The clinical presentation of each patient
prompted the referring physician to perform endomyocardial
biopsy to exclude myocarditis.
Analysis of endomyocardial biopsy specimen. Endomyo-
cardial biopsies were taken transvenously via the femoral
approach from the right heart side of the interventricular
septum. From each patient, several biopsies (at least five) were
analyzed. The endomyocardial biopsies were examined histo-
logically according to the Dallas Criteria (6). The histologic
sections were analyzed by light microscopy for evidence of
myocardial necrosis, interstitial fibrosis and for the presence of
lymphocytic infiltrates. As the histologic evaluation of myocar-
dial biopsies is known to be difficult and affected by many
problems (21,22), including high interobserver variability (7)
and sampling error (5), the biopsy specimens were therefore
examined additionally with immunohistologic techniques using
various monoclonal antibodies. Antibodies directed against
surface antigens of human lymphocytes (CD3, CD4, CD8)
were used to detect and quantitate lymphocytic infiltrates in
myocardial tissue (8 –13). Additionally, using antibodies
against the major histocompatibility antigens (MHC), the
expression of MHC I and II antigens was analyzed. With these
techniques, the diagnostic accuracy in the biopsies could be
increased (11) and the interobserver variability could be min-
imized (12,13).
The biopsy specimens were classified as “acute myocarditis”
when histologic sections of endomyocardial biopsies revealed
lymphocytic infiltrates in the neighborhood of myocardial
necrosis (6). “Borderline myocarditis” was diagnosed when
lymphocytic infiltrates were present in histologic sections with-
out myocyte necrosis (6). When the immunohistologic analysis
revealed pathologically increased lymphocytic infiltrates (.2.0
lymphocytes/high power field) (23) and an increased expres-
sion of MHC I and II antigens, the biopsy was classified as
lymphocytic myocarditis. When neither the histologic nor the
immunohistologic analysis revealed myocytolysis or lympho-
cytic infiltrates, the biopsies were classified as no myocarditis.
Antimyosin scintigraphy. All antimyosin scintigraphy stud-
ies were done within 3 weeks of the time of myocardial biopsy,
the interval being mainly dependent on patient’s agreement
and organizational factors such as availability of antibody and
tracer.
Each patient was given 0.5 mg of R11D10-Fab-DPTA
monoclonal antimyosin antibodies labeled with 75 MBq of
indium-111 (Myoszint, Centocor, The Netherlands) intrave-
nously. Imaging was done in the anterior and lateral projec-
tions at 30 min after the injection to view the heart chambers,
and 24 h or 48 h after the injection of the radiopharmacon to
assess the presence of the antimyosin antibodies in the myo-
cardial wall. Images were taken with a large field-of-view high
resolution camera, using a medium energy all purpose colli-
mator and two 20% windows centered on 247 and 173 keV
peaks. Images were collected for 10 min into a 128 3 128 pixel
matrix.
Analysis of the antimyosin scintigraphy was done by visual
interpretation and by calculating the heart/lung ratio. The
accumulation of the antimyosin antibodies in the myocardial
wall was classified visually by an experienced observer unaware
of the clinical data in the anterior and the lateral projections,
respectively, comparing the images taken 30 min and 24 or 48 h
after injection of the antimyosin antibodies, respectively. An-
timyosin uptake was assessed semiquantitatively as 0 5 no
myocardial uptake, 1 5 faint/mild uptake, 2 5 clear uptake,
3 5 intense uptake. The heart/lung ratio was calculated in the
anterior view by dividing the average counts per pixel over the
myocardium by the average counts per pixel over the lung. A
ratio #1.6 was considered normal, a ratio .1.6 was considered
pathologic. The heart/lung ratio was not determined in the
lateral view because exact definition of the lung region often
proved to be difficult in this view. Visual analysis, which
compared the size of the radioactive heart region 48 h after
antibody injection with the size of the blood pool activity
Abbreviations and Acronyms
AMS1 5 patients with a positive antimyosin scan
AMS2 5 patients with a normal antimyosin scan
MHC 5 major histocompatibility complex
NS 5 not significant
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30 min after injection, was superior to the calculation of the
heart/lung ratio in detecting antibody accumulation in the
myocardial wall in patients with large left ventricles where high
blood pool activity increased the heart/lung ratio even in the
absence of antibody accumulation in the myocardial wall. A
positive antimyosin scan is demonstrated in Figure 1.
Statistical analysis. Agreement between antimyosin scin-
tigraphy and biopsy results was measured using Fisher’s exact
test (two-tailed) or the chi-square test. Continuous variables
were analyzed with the unpaired t test; p values ,0.05 were
considered to indicate statistical significance.
Results
Antimyosin scintigraphy in patients with clinically sus-
pected myocarditis. The results of the antimyosin scintigraphy
in the 65 patients are shown in Table 1. The heart/lung ratio in
the anterior view ranged from 1.20 to 2.30 (mean 1.69 6 0.26)
and was pathologic in 33 (51%) patients. By visual analysis,
antimyosin antibody uptake in the myocardial wall was detect-
able in 36 (55%) of 65 patients. Eight of 36 patients with
visually detectable antimyosin accumulation in the myocardial
wall had a normal heart/lung ratio. Three of the eight patients
had antimyosin deposition only in inferobasal region of the
heart; in five patients the tracer uptake was distributed dif-
fusely over the myocardium. In 5 of 29 patients with no visible
accumulation of antimyosin antibodies in the ventricular wall,
the heart/lung ratio was .1.6. The left ventricular end diastolic
volumes of these patients tended to be larger (437 6 132 ml)
than the left ventricular end diastolic volumes of the patients
with a heart/lung ratio ,1.6 (252 6 134 ml) (p 5 NS). The
heart/lung ratio seemed to be increased because of a higher
blood pool activity in the ventricles rather than accumulation
of antibodies in the ventricular wall. For comparison of
scintigraphic results with findings in the endomyocardial biop-
sies, scans with clear accumulation of antimyosin antibodies in
the ventricular wall but a heart/lung ratio #1.6 were consid-
ered positive; scans without visible antibody accumulation in
the ventricular wall but a heart/lung ratio .1.6 were consid-
ered negative. Finally, 36 (55%) antimyosin scans were con-
sidered positive and 29 (45%) antimyosin scans were consid-
ered negative. Four patients presented with elevated creatine
kinase levels. Two of these patients had a positive antimyosin
scintigraphy; in two patients the antimyosin scintigraphy was
normal.
Antimyosin scintigraphy and results of endomyocardial
biopsy. In patients with a positive antimyosin scan (AMS1),
myocarditis was diagnosed (histologically and/or immunohis-
tologically) in 31 of 36 patients (86%); in 5 AMS1 patients
(14%) the endomyocardial biopsy was negative for myocarditis
(Fig. 2). In patients with a normal antimyosin scan (AMS2),
evidence for myocarditis in the endomyocardial biopsy was
found histologically and/or immunohistologically in 17 of 29
patients (59%). In 12 AMS-patients (41%), the biopsy did not
reveal any sign of myocarditis. In 10 patients, antimyosin
scintigraphy and endomyocardial biopsy were performed
within 6 weeks of the onset of symptoms. The antimyosin scan
was positive in five patients and negative in the remaining five
patients. Evidence of myocarditis was detected in the endo-
myocardial biopsy in all of these patients. The sensitivity of the
antimyosin scintigraphy for the detection of myocarditis (his-
tologically and/or immunohistologically) was 66%, the speci-
Figure 1. Digitalized antimyosin scan with color coding of regional
pulse rates recorded 48 h after administration of 0.5 mg of R11D10-
Fab-DPTA monoclonal antimyosin antibodies labeled with 75 MBq of
indium-111 intravenously. The most intense staining is located over the
liver (thick arrow), but staining of the ventricular wall is also clearly
visible (thin arrows).
Figure 2. Antimyosin scintigraphy and findings in the endomyocardial
biopsy in 65 patients with clinically suspected myocarditis. The anti-
myosin scan (AMS) was considered positive (1) when antimyosin
antibody uptake in the ventricular wall was clearly visible; the endo-
myocardial biopsy was considered positive when histologic and/or
immunohistologic evidence of myocarditis was detected.
Table 1. Visual Uptake of Antimyosin Antibodies in the
Ventricular Wall
0–1 2–3
Heart/lung ratio #1.6 24 8
.1.6 5 28
Antimyosin scintigraphy in 65 patients with clinically suspected myocarditis.
Heart/lung ratio and visual assessment of antimyosin antibody uptake in the
ventricular wall. The heart/lung ratio was calculated in the anterior view by
dividing the average counts per pixel over the myocardium by the average counts
per pixel over the lung. Antimyosin antibody uptake into the ventricular wall was
assessed semiquantitatively as 0–1 5 no or faint/mild uptake, 2–3 5 clear or
intense uptake.
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ficity 71%, the predictive value of an abnormal scan 86%, the
predictive value of a normal scan 42% and the effectiveness
66%.
Separate analysis of histologic and immunohistologic re-
sults of the endomyocardial biopsies is shown in Figure 3.
Histologic analysis of the endomyocardial biopsy specimen
alone revealed evidence of myocarditis in 6 (17%) of 36
AMS1 patients (1 patient with acute myocarditis, 5 patients
with borderline myocarditis) and in 3 (10%) of 29 AMS2
patients (3 patients with borderline myocarditis). No evidence
of myocarditis was found by histologic examination alone in 30
(83%) of 36 AMS1 patients and in 26 (90%) of 29 AMS2
patients (p , 0.720; NS). Four patients presented with initially
elevated creatine kinase levels. Myocarditis was diagnosed
histologically in one of these patients (with a positive antimyo-
sin scan); no evidence of myocarditis was found histologically
in three patients. With right ventricular histologic findings as
the diagnostic method for the presence of myocarditis, the
diagnostic value of the antimyosin scintigraphy had to be
calculated as follows: sensitivity, 67%; specificity, 46%; predic-
tive value of an abnormal scan, 17%; predictive value of a
normal scan, 90%.
Immunohistologic examination of the endomyocardial bi-
opsy specimen showed lymphocytic myocarditis in 31 (86%) of
36 AMS1 patients; 6 of these patients also had evidence of
myocarditis in histologic analysis and 25 patients were histo-
logically negative for myocarditis. Lymphocytic myocarditis
was detectable by immunohistologic examination also in 17
(59%) of 29 patients with a negative antimyosin scan (p ,
0.047); 3 of these patients had histologically diagnosed myo-
carditis and 14 patients were histologically negative for myo-
carditis. In all four patients with initially elevated creatine
kinase levels, immunohistologic analysis of the endomyocardial
biopsy revealed evidence of myocarditis. No evidence of
myocarditis was found immunohistologically in 5 (14%) of 36
AMS1 patients and in 12 (41%) of 29 AMS2 patients. With
right ventricular immunohistologic findings as the diagnostic
method for the presence of myocarditis, the diagnostic value of
the antimyosin scintigraphy had to be calculated as follows:
sensitivity, 65%; specificity, 71%; predictive value of an abnor-
mal scan, 86%; predictive value of a normal scan, 41%.
Antimyosin scintigraphy and hemodynamic measurements.
The mean ejection fraction of all patients was 50.1 6 21.0%
(range 21% to 85%). There was no difference in the ejection
fraction between patients with a positive (48.4 6 17.6%) and a
negative (52.4 6 24.7%) antimyosin scan (p 5 NS) or between
patients with myocarditis (51.2 6 20.2%) and without myocar-
ditis (47.0 6 23.0%) (p 5 NS). The ejection fraction of patients
with myocarditis and a positive antimyosin scan (50.2 6 17.7)
was higher than the ejection fraction of patients with a positive
antimyosin scan and no evidence of myocarditis (35.5 6 10.3),
but this difference did not reach statistical significance (p ,
0.082). The ejection fraction of patients with myocarditis and a
positive antimyosin scan (50.2 6 17.7) was not different from
the ejection fraction of patients with myocarditis and a nega-
tive antimyosin scan (53.5 6 24.4) (p 5 NS). The mean end
diastolic volume of all patients was 265 6 122 ml (range 68 to
625 ml). There was also no difference in the end diastolic
volume between patients with a positive (252 6 96 ml) and a
negative (283 6 148 ml) antimyosin scan (p 5 NS) or between
patients with myocarditis (258 6 112 ml) and without myocar-
ditis (287 6 122 ml) (p 5 NS).
Discussion
Previous studies investigated the diagnostic value of anti-
myosin scintigraphy in patients with myocarditis and dilated
cardiomyopathy (18–20,24). They correlated antimyosin scin-
tigraphy with the results of the histologic analysis of the
endomyocardial biopsy, classified according to the Dallas
Criteria (6), and found a high sensitivity but a low specificity of
the antimyosin scintigraphy for the detection of myocarditis
with many scintigraphically positive cases in which the endo-
myocardial biopsy failed to show myocarditis on histologic
analysis. In the present study, similar values for sensitivity and
specificity of the antimyosin scintigraphy for the detection of
myocarditis were found, with histologic analysis of the endo-
myocardial biopsy as the reference method. However, similar
to other studies (18–20), the majority of patients with a
positive antimyosin scan were histologically negative for myo-
carditis. This group of patients had been classified by Obrador
et al. (20) as dilated cardiomyopathy with unexplained ongoing
myocardial cell damage. Several possible explanations for the
discrepancy between antimyosin scintigraphy and endomyocar-
dial biopsy have been discussed, including subendothelial
necrosis due to cardiac dilatation, a focal nature of myocardi-
tis, persistent viral infection of the myocardium or sampling
error of the biopsies (18,20). The histologic evaluation of
myocardial biopsies alone is known to be difficult and affected
by many problems (21,22), including high interobserver vari-
Figure 3. Antimyosin scintigraphy and separate analysis of histologic
and immunohistologic findings in the endomyocardial biopsy in 65
patients with clinically suspected myocarditis. AMS 5 antimyosin
scintigraphy. 1 5 positive antimyosin scan with clear antimyosin
antibody uptake in the ventricular wall. 2 5 negative antimyosin scan
with no clear antimyosin antibody uptake in the ventricular wall.
Histo 5 results of histologic analysis of the endomyocardial biopsy;
acute MC 5 acute myocarditis; bord MC 5 borderline myocarditis; no
MC 5 no myocarditis. ImHisto 5 results of immunohistologic analysis
of the endomyocardial biopsy; lymph MC 5 lymphocytic myocarditis;
no MC 5 no myocarditis.
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ability (7) and sampling error (5). Therefore, in the present
study the biopsy specimens were analyzed additionally with
immunohistologic techniques (8–11). Using these methods,
Ku¨hl et al. (23) found evidence of ongoing myocardial inflam-
mation in 48% of patients presenting with a clinical picture of
dilated cardiomyopathy and no evidence of myocarditis on
histologic analysis. However, it has to be pointed out that the
pathophysiologic reason responsible for the myocardial inflam-
mation, whether it is viral, ischemic, toxic or other, cannot be
detected by immunohistologic analysis of the endomyocardial
biopsy. To identify the pathophysiologic agent, other tech-
niques such as in situ hybridization (25) or the polymerase
chain reaction (26) for the detection of viral genome in the
myocardium have to be employed.
Antimyosin scintigraphy and immunohistologic analysis of
the endomyocardial biopsy. The present study provides the
first report that compares antimyosin scintigraphy with immu-
nohistologic analysis of the endomyocardial biopsy in patients
with clinically suspected myocarditis. The prevalence of a
positive antimyosin scan was similar to the results of previously
reported studies (18–20). Histologic analysis of the endomyo-
cardial biopsy specimen alone could establish the diagnosis of
myocarditis only in a small number of these patients. However,
additional immunohistologic evaluation revealed evidence of
myocarditis in most of the patients with a positive antimyosin
scan. With immunohistologic analysis of the endomyocardial
biopsy as the reference method, the antimyosin scintigraphy
has a high specificity and a lower sensitivity for the detection of
myocarditis. The positive predictive value of antimyosin scin-
tigraphy is high; the negative predictive value is low for the
detection of myocarditis with immunohistologic analysis as the
reference method.
The present studies underscore the low diagnostic sensitiv-
ity of the histologic analysis of endomyocardial biopsy both for
the detection of myocyte damage and myocardial inflamma-
tion, respectively. Therefore, the diagnosis of myocarditis
should not be based on histologic analysis of the endomyocar-
dial biopsy alone. The presence of myocarditis should also be
considered if immunohistologic analysis of the endomyocardial
biopsy shows lymphocytic infiltrates and an activated immuno-
logic process, and if evidence of ongoing myocardial damage
can be demonstrated, either by antimyosin scintigraphy or
probably by measurement of cardiac troponin T (27).
Discrepancies between antimyosin scintigraphy and endo-
myocardial biopsy. A positive antimyosin scan was also found
in 5 of 36 patients who had negative biopsy findings in both
histologic and immunohistologic analysis, respectively. Visual
analysis of the antimyosin scans showed that three of these
patients had antimyosin antibody accumulation only in the
dorsal or lateral parts of the left ventricle. Apparently, myo-
cardial damage was not evenly distributed over the entire heart
in these patients but rather a more focal process was present
only in some heart regions. As the endomyocardial biopsy is
taken from the interventricular septum, it is likely that the
diagnosis might be missed in patients with focal myocarditis
only in other regions of the heart. In two patients, the biopsy
was negative histologically and immunohistologically despite a
uniform distribution of staining over the left ventricle. In these
patients, the diagnosis of myocarditis possibly may be missed
because of a sampling error of the endomyocardial biopsy,
probably due to the “patchy” nature of the myocardial inflam-
mation on a microscopical scale. The ejection fraction of
patients with a positive antimyosin scan and no evidence of
myocarditis was somewhat lower than the ejection fraction of
patients with myocarditis and a positive antimyosin scan so that
other pathogenetic mechanisms like subendocardial ischemia
may also be responsible for the presence of myocardial cell
damage and a positive antimyosin scan in the absence of
myocardial inflammation.
Immunohistologic analysis of endomyocardial biopsy also
found evidence of myocardial inflammation in 17 of 29 patients
with a normal antimyosin scan. Seven of these patients showed
a prominent blood pool activity even 48 h after the injection of
the antimyosin antibodies; the heart/lung ratio was elevated in
five of these seven patients. It cannot be ruled out that high
blood pool activity precluded the detection of antibody depo-
sition in the ventricular wall (24). It is also possible that the
extent of myocardial cell damage in these patients was too low
to be detected by antimyosin scintigraphy. However, it has to
be pointed out that the presence of lymphocytic infiltrates in
the myocardium does not necessarily imply lymphocyte-
mediated myocyte necrosis. Another explanation would be that
different time frames exist for the presence of myocardial
necrosis (leading to a positive antimyosin scan) and myocardial
inflammation (leading to the detection of lymphocytic infil-
trates in the endomyocardial biopsy) in the course of the
disease “myocarditis,” thus explaining the observed differences
between the two diagnostic methods.
On the other hand, different pathogenetic mechanisms for
the presence of myocardial damage and myocardial inflamma-
tion might be responsible for the discrepancies between anti-
myosin scintigraphy and endomyocardial biopsy.
Possible pathogenetic mechanisms for myocardial damage
and inflammation in patients with myocarditis. Using in situ
hybridization or the polymerase chain reaction, viral RNA has
been detected in the myocardium of patients with myocarditis
(25,26,28). In these patients the viral infection is discussed as
the pathogenetic mechanism of myocardial inflammation. It
cannot be ruled out that the presence of viral structures itself
may cause migration of inflammatory cells into the myocar-
dium without actual myocyte damage. In this case, lymphocytic
infiltrates would be found in the endomyocardial biopsy but
the antimyosin scan would be negative.
Other studies detected autoantibodies against various car-
diac antigens in patients with myocarditis (29–33), including
autoantibodies against cardiac myosin (34). Antimyosin auto-
antibodies might possibly interfere with the accumulation of
the radioactively labeled antimyosin antibodies used for scin-
tigraphy. The pathogenetic role of the autoantibodies against
cardiac antigens in the course of myocarditis is not yet clear.
One possible explanation would be “molecular mimicry.”
Schwimmbeck et al. (35) identified regions of high homology
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between Coxsackie B3 virus and cardiac myosin. Using syn-
thetic peptides identical to these regions, an immunologic
cross-reactivity between Coxsackie B3 virus peptides and car-
diac myosin peptides was demonstrated. In contrast, the
antimyosin antibodies produced in Coxsackie B3 virus-induced
myocarditis in A/J mice did not crossreact with the virus (36).
Recently, evidence of apoptosis (or “programmed” cell
death) was detected in the myocardium of patients with
chronic heart failure due to dilated cardiomyopathy (37). In
contrast to necrosis (or “accidental” cell death), apoptosis is a
tightly regulated process driven by a genetic program (38). It
cannot be ruled out that apoptosis occurred also in patients in
the present study and that apoptosis does not necessarily lead
to exposition of intracellular myosin to the extracellular space
so that the antimyosin scan might be negative in these cases.
Conclusions. The present study shows that myocardial dam-
age can often be detected in patients with clinically suspected
myocarditis by use of antimyosin scintigraphy. Histologic analysis
of the endomyocardial biopsy alone is often negative, but addi-
tional immunohistologic analysis of the endomyocardial biopsy
frequently provides evidence of myocardial inflammation in these
patients. With immunohistologic analysis as the reference, anti-
myosin scintigraphy has a high specificity but a lower sensitivity
for the detection of myocarditis.
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